
Ranked #2 in the nation for Neurology and Neurosurgery
Make an Appointment
News
- May 24, 2022
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
Topic
- May 22, 2022
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease.
Topic
- May 10, 2022
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
Topic
Events
- Wednesday, June 1, 20225:30 PM to 6:30 PM
Venue
Online Event Zoom Meeting - Thursday, June 9, 20222:00 PM to 3:30 PM
Venue
Online - Thursday, June 16, 20227:00 AM to 8:00 AM